Mölnlycke to relocate HQ to GoCo Health Innovation City
In late 2024 Mölnlycke will relocate to brand new headquarters in GoCo Health Innovation City in Mölndal. The new headquarters will have a total area of 16,000 m2 and will be located in one of GoCo's prime locations, with capacity for around 800 associates.
Today, Mölnlycke is announcing that the company will move to a newly built headquarters in GoCo Health Innovation City in Mölndal. The move is scheduled to be completed in late 2024 and will bring together all Mölnlycke's office-based associates in Sweden in the activity-based office.
Zlatko Rihter, president and group CEO comments:
'We are delighted to take the next steps towards realising a new head office in world-class. The new headquarters will be built from scratch and will be entirely based on our needs and will include, among other things, a first-class R&D facility, flexible collaboration spaces and a fantastic working environment. The relocation to GoCo Health Innovation City also means that we will be even closer and more linked to Gothenburg's leading life science cluster, further supporting our R&D intense business and our ambition to become a global leader in medical products and solutions, to serve our customers even better.'
The new headquarters will have a total area of 16,000 m2 and will be located in one of GoCo's prime locations, with capacity for around 800 associates. The office is designed to establish a new level of flexibility for the company's working environments, aimed to meet the many different needs of the employees for collaboration and socialising, as well as platforms for individual focus and project work. As remote work will continue to be an important part of Mölnlycke's way of working going forward, the new office is activity-based and tailored to meet the needs of on-site employees, as well as a seamless link for those who work remotely. The new headquarters will have the highest possible environmental rating, Platinum, according to LEED, which supports Mölnlycke's ambition within sustainability.
Mölnlycke will be a Founding Partner of GoCo Arena – a meeting place and collaboration platform for the life science sector – which means that Mölnlycke will be involved in setting the agenda for the use of the arena.
GoCo Health Innovation City is an area in Mölndal with a focus on health and life sciences, bringing together companies, researchers, entrepreneurs and talent from around the world to share ideas and collaborate to find tomorrow's health innovations.
For more information, please contact:
Magnus Nordberg, Communications Manager Business Partner,
email: magnus.nordberg@molnlycke.com
phone: +46 739 41 29 98
About Mölnlycke
Mölnlycke is a world-leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. We design and supply products and solutions for use in wound treatment, pressure ulcer and infection prevention and surgery.
Mölnlycke employs around 8000 people. The company headquarters are in Gothenburg, Sweden and we operate in more than 100 countries worldwide. Since 2007, the company is part of Investor AB, an engaged owner of high-quality, global companies which was founded by the Wallenberg family in 1916. For more information, please visit www.molnlycke.com.
